As biopharmaceutical enterprises advance from R&D to clinical development, commercialization and global operations, the complexity of enterprise‑wide management data continues to grow. Data pertaining to R&D projects, CRO/CDMO engagements, procurement, contracts, expenses, milestones, revenue and finance are often siloed across ERP, CRM, Excel spreadsheets and other business systems.
The real challenge lies not in excessive data volume, but in disconnected data.
Common Management Challenges Facing Biotech Enterprises
- Difficulty in accurately tracking R&D project costs
- Fragmented data for CRO/CDMO contracts and projects
- Lack of consistent standards for budgets, procurement, expenses and financial data
- Complex administration of license‑out transactions and milestone‑based revenue
- Multi‑entity and multi‑currency management requirements stemming from overseas subsidiaries
- Demands for enhanced data traceability and governance during IPO preparation
What Can an ERP Deliver？
For growing biotech companies, ERP is far more than a financial system — it serves as a unified operations platform bridging business and finance.
Powered by Oracle NetSuite, enterprises can progressively unify: Finance + Projects + Procurement + Contracts + Inventory + Multi‑Entity + Reporting
It connects project, contract, procurement, cost, revenue and financial datasets, laying a unified and traceable foundation for operational data across the organization.
Why Melin？
Melin Technology leverages Oracle NetSuite to deliver end‑to‑end digital services for biotech, CRO and CDMO clients, covering ERP implementation, data migration, system integration and ongoing operational support.
Our goal is not merely to “go‑live with an ERP”, but to help enterprises build a digital operation foundation that underpins scaling, global expansion and IPO readiness.
Better data. Better decisions. Better growth.
